1. Home
  2. AWRE vs EVAX Comparison

AWRE vs EVAX Comparison

Compare AWRE & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.73

Market Cap

40.2M

Sector

Technology

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.36

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
EVAX
Founded
1986
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
33.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AWRE
EVAX
Price
$1.73
$3.36
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
21.7K
76.2K
Earning Date
03-04-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$7,650,000.00
Revenue This Year
N/A
$128.77
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
132.17
52 Week Low
$1.37
$1.20
52 Week High
$2.95
$12.15

Technical Indicators

Market Signals
Indicator
AWRE
EVAX
Relative Strength Index (RSI) 37.83 38.78
Support Level $1.70 $3.06
Resistance Level $1.83 $3.66
Average True Range (ATR) 0.09 0.33
MACD -0.00 0.04
Stochastic Oscillator 18.52 37.25

Price Performance

Historical Comparison
AWRE
EVAX

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: